Portfolio company
AN2 Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
Digital Health
About
This biopharmaceutical company develops small-molecule boron-based therapeutics to treat patients with rare, chronic, and serious infectious diseases and certain types of cancer.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.